Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
2024 World Cancer Congress
ESMO Congress 2024
2024 IASLC WCLC
2024 Debates and Didactics in Hematology and Oncology
European Association for the Study of Diabetes Annual Meeting 2024
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Search Results
Advertisement
«
1
»
Advertisement
Advertisement
Sep
17
Today In Oncology
Studies Show Immunotherapy Improves Long-Term Survival in Growing Number of Cancers
Retifanlimab Plus Chemotherapy May Extend Progression Free Survival in Patients With Squamous Cell Anal Carcinoma
Cancer Deaths of 5.5 Million Men Worldwide Have Led to 1.41 Million New Paternal Orphans
Study Finds Nearly $70 Billion in Socioeconomic Losses Across 11 Countries Attributable to Ovarian Cancer
Novel Antibody Drug Conjugate Puxitatug Samrotecan May Demonstrate Manageable Safety Profile and Preliminary Efficacy in First in Human Trial
View More
Advertisement
